Chemours Reports Q3 Non-GAAP EPS Miss Amid Revenue Beat
Chemours (NYSE: CC) reported third-quarter financial results characterized by a mixed performance. While the company achieved revenue of $1.54 billion, representing a 2.7% increase year-over-year and exceeding analyst expectations by $10 million, its Non-GAAP earnings per share (EPS) of $0.21 fell short of estimates by $0.05. Looking ahead to the fourth quarter, Chemours provided a cautious outlook, forecasting a decrease in consolidated net sales within the range of 5%. This guidance suggests potential headwinds for the company's top-line growth heading into the end of the fiscal period.
Tickers: $CC